APA (7th ed.) Citation

FCA, d. M., GTFU, M., LHRM, R., VKT, S., JB, G., & RMR, B. (2026). Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis. Expert review of anticancer therapy, 26(5), 629. https://doi.org/10.1080/14737140.2025.2602802

Chicago Style (17th ed.) Citation

FCA, de Moraes, Matheus GTFU, Rego LHRM, Sano VKT, Gazabón JB, and Burbano RMR. "Do Genetic Polymorphisms Influence Imatinib Trough Concentrations in Patients with Chronic Myeloid Leukemia? A Systematic Review and Meta-analysis." Expert Review of Anticancer Therapy 26, no. 5 (2026): 629. https://doi.org/10.1080/14737140.2025.2602802.

MLA (9th ed.) Citation

FCA, de Moraes, et al. "Do Genetic Polymorphisms Influence Imatinib Trough Concentrations in Patients with Chronic Myeloid Leukemia? A Systematic Review and Meta-analysis." Expert Review of Anticancer Therapy, vol. 26, no. 5, 2026, p. 629, https://doi.org/10.1080/14737140.2025.2602802.